{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:25:52Z","timestamp":1791170752782,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.nbd.2015.02.019","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T02:09:23Z","timestamp":1425089363000},"page":"49-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease"],"prefix":"10.1016","volume":"77","author":[{"given":"Elpida","family":"Tsika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An Phu Tran","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dusonchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard L.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.02.019_bb0190","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1093\/hmg\/ddp346","article-title":"LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model","volume":"18","author":"Alegre-Abarrategui","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.02.019_bb0130","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/hmg\/dds522","article-title":"GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2","volume":"22","author":"Biosa","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.02.019_bb0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbadis.2008.09.015","article-title":"Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease","volume":"1792","author":"Biskup","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2015.02.019_bb0340","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/104454902762053864","article-title":"Gene delivery using herpes simplex virus vectors","volume":"21","author":"Burton","year":"2002","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0315","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/cdd.2012.42","article-title":"(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD","volume":"19","author":"Chen","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2015.02.019_bb0290","first-page":"658","article-title":"Brain penetrant LRRK2 inhibitor","volume":"3","author":"Choi","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0140","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/hmg\/ddr618","article-title":"Sustained expression of PGC-1alpha in the rat nigrostriatal system selectively impairs dopaminergic function","volume":"21","author":"Ciron","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.02.019_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/375061a0","article-title":"Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"375","author":"Collard","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.02.019_bb0335","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrn1104","article-title":"Viral vectors for gene delivery to the nervous system","volume":"4","author":"Davidson","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.019_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/BJ20121742","article-title":"Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies","volume":"453","author":"Davies","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2015.02.019_bb0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nchembio.538","article-title":"Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2","volume":"7","author":"Deng","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0235","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0306-4522(97)00354-0","article-title":"Neuronal damage after the injection of amino-oxyacetic acid into the rat entorhinal cortex: a silver impregnation study","volume":"82","author":"Du","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.02.019_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nbd.2009.03.013","article-title":"Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease","volume":"35","author":"Dusonchet","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.02.019_bb0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1523\/JNEUROSCI.5092-10.2011","article-title":"A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2","volume":"31","author":"Dusonchet","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.019_bb0305","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1021\/jm301020q","article-title":"Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors","volume":"55","author":"Estrada","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2015.02.019_bb0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0065","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.20484","article-title":"An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family","volume":"57","author":"Funayama","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0185","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/118.6.1447","article-title":"Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease","volume":"118","author":"Gai","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.02.019_bb0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10520298009067257","article-title":"A reliable method for demonstrating axon degeneration shortly after axotomy","volume":"55","author":"Gallyas","year":"1980","journal-title":"Stain. Technol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0085","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.20808","article-title":"LRRK2 expression linked to dopamine-innervated areas","volume":"59","author":"Galter","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbadis.2008.12.007","article-title":"Mendelian forms of Parkinson's disease","volume":"1792","author":"Gasser","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2015.02.019_bb0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00401-012-0963-y","article-title":"Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity","volume":"123","author":"Gaugler","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","article-title":"Biochemical and pathological characterization of Lrrk2","volume":"59","author":"Giasson","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/hmg\/ddr481","article-title":"Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP","volume":"21","author":"Gomez-Suaga","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.02.019_bb0270","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.02.019_bb0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0295","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/jm5014055","article-title":"Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor","volume":"58","author":"Henderson","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2015.02.019_bb0325","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0301-0082(98)00007-0","article-title":"Viral vectors, tools for gene transfer in the nervous system","volume":"55","author":"Hermens","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0125","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","article-title":"LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice","volume":"20","author":"Herzig","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.02.019_bb0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2007.04.034","article-title":"Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain","volume":"1155","author":"Higashi","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.02.019_bb0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.2006.04246.x","article-title":"Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain","volume":"100","author":"Higashi","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.02.019_bb0265","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20070209","article-title":"LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity","volume":"405","author":"Jaleel","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2015.02.019_bb0220","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2015.02.019_bb0070","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1093\/brain\/awh667","article-title":"Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data","volume":"128","author":"Khan","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.02.019_bb0225","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2015.02.019_bb0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0955-0674(94)90113-9","article-title":"Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease","volume":"6","author":"Lee","year":"1994","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.ne.19.030196.001155","article-title":"Neuronal intermediate filaments","volume":"19","author":"Lee","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.019_bb0310","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.2199","article-title":"Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease","volume":"16","author":"Lee","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2015.02.019_bb0330","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2011.09.014","article-title":"Viral vectors for gene delivery to the central nervous system","volume":"48","author":"Lentz","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.02.019_bb0165","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.019_bb0170","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","article-title":"Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.019_bb0215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","article-title":"The familial Parkinsonism gene LRRK2 regulates neurite process morphology","volume":"52","author":"MacLeod","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.02.019_bb0105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.nbd.2012.07.017","article-title":"LRRK2 expression is enriched in the striosomal compartment of mouse striatum","volume":"48","author":"Mandemakers","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.02.019_bb0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neuroscience.2006.01.017","article-title":"Anatomical localization of leucine-rich repeat kinase 2 in mouse brain","volume":"139","author":"Melrose","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.02.019_bb0175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","article-title":"Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice","volume":"40","author":"Melrose","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.02.019_bb0350","first-page":"389","article-title":"Construction of first-generation adenoviral vectors","volume":"69","author":"Ng","year":"2002","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.nbd.2015.02.019_bb0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's Disease","volume":"44","author":"Pais\u00e1n-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.02.019_bb0365","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2009"},{"key":"10.1016\/j.nbd.2015.02.019_bb0200","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","article-title":"Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells","volume":"105","author":"Plowey","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.02.019_bb0060","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","article-title":"Parkinsonism, Lrrk2 G2019S, and tau neuropathology","volume":"67","author":"Rajput","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.02.019_bb0195","doi-asserted-by":"crossref","first-page":"e18568","DOI":"10.1371\/journal.pone.0018568","article-title":"Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2","volume":"6","author":"Ramonet","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.02.019_bb0285","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/cb2002413","article-title":"Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons","volume":"6","author":"Ramsden","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","article-title":"Lrrk2 and Lewy body disease","volume":"59","author":"Ross","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.02.019_bb0205","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/emmm.201200215","article-title":"Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease","volume":"4","author":"Sanchez-Danes","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2015.02.019_bb0030","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2015.02.019_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e318264e353","article-title":"Large-scale replication and heterogeneity in Parkinson disease genetic loci","volume":"79","author":"Sharma","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.02.019_bb0300","doi-asserted-by":"crossref","first-page":"164ra161","DOI":"10.1126\/scitranslmed.3004485","article-title":"Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations","volume":"4","author":"Sheng","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2015.02.019_bb0180","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.02.019_bb0025","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2015.02.019_bb0345","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","article-title":"Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration","volume":"102","author":"Smith","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.02.019_bb0275","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","article-title":"Kinase activity of mutant LRRK2 mediates neuronal toxicity","volume":"9","author":"Smith","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.019_bb0155","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.02.019_bb0110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1471-4159.2006.03919.x","article-title":"Distribution of PINK1 and LRRK2 in rat and mouse brain","volume":"98","author":"Taymans","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.02.019_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11910-012-0265-8","article-title":"Mechanisms of LRRK2-mediated neurodegeneration","volume":"12","author":"Tsika","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nbd.2015.02.019_bb0255","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.02.019_bb0260","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.02.019_bb0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuroscience.2007.10.062","article-title":"Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease","volume":"152","author":"Westerlund","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.02.019_bb0055","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/01.WNL.0000125015.06989.DB","article-title":"Autosomal dominant parkinsonism associated with variable synuclein and tau pathology","volume":"62","author":"Wszolek","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.02.019_bb0355","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neuron.2009.07.028","article-title":"Synaptotagmin has an essential function in synaptic vesicle positioning for synchronous release in addition to its role as a calcium sensor","volume":"63","author":"Young","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.02.019_bb0360","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/viro.2000.0515","article-title":"a new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors","volume":"275","author":"Zhou","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.nbd.2015.02.019_bb0320","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7150\/ijbs.7.753","article-title":"Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake","volume":"7","author":"Zhou","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.nbd.2015.02.019_bb0010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.02.019_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/380647","article-title":"The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval","volume":"74","author":"Zimprich","year":"2004","journal-title":"Am. J. Hum. Genet."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T11:09:33Z","timestamp":1566385773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":73,"alternative-id":["S0969996115000534"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.02.019","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}